Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01316484 · ClinicalTrials.gov registry record
Patient Understanding (Cognitive Debriefing) of a Daily Diary of Gastroparesis Symptoms
A clinical trial, sponsored by Tranzyme.
- Completed
- Registry status
- 40
- Enrollment target
NCT01316484: Completed study, sponsored by Tranzyme.
NCT01316484 is a clinical trial that has completed, run by Tranzyme. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01316484 has completed, sponsored by Tranzyme.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
The primary objective of the study is to evaluate how patients with gastroparesis interpret the instructions, item content, and response options of a daily diary questionnaire designed to assess the key symptoms of gastroparesis.
Primary Outcome
The cognitive debriefing data will be content analyzed for patient understanding of the concepts in the questionnaire and interpretation of the items' content.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2011-03 |
| Est. Completion | 2011-04 |
What the finished NCT01316484 record still lists
NCT01316484 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01316484 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01316484 about?
NCT01316484 is a clinical study titled "Patient Understanding (Cognitive Debriefing) of a Daily Diary of Gastroparesis Symptoms". The primary objective of the study is to evaluate how patients with gastroparesis interpret the instructions, item content, and response options of a daily diary questionnaire designed to assess the key symptoms of gastroparesis.
What is the current status of trial NCT01316484?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2011-03. Estimated completion is 2011-04.
Who is sponsoring clinical trial NCT01316484?
This trial is sponsored by Tranzyme, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia